Patents by Inventor Albina Nesterova

Albina Nesterova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
    Publication number: 20200165335
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: February 6, 2020
    Publication date: May 28, 2020
    Inventors: Maria Leia SMITH, Django SUSSMAN, William ARTHUR, Albina NESTEROVA
  • Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
    Publication number: 20180079810
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: August 31, 2017
    Publication date: March 22, 2018
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Humanized antibodies to LIV-1 and use of same to treat cancer
    Patent number: 9783608
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: October 10, 2017
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
    Publication number: 20160185858
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: November 20, 2015
    Publication date: June 30, 2016
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Humanized antibodies to LIV-1 and use of same to treat cancer
    Patent number: 9228026
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: January 5, 2016
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
    Publication number: 20130259860
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Application
    Filed: December 6, 2011
    Publication date: October 3, 2013
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova
  • Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133)
    Publication number: 20100040637
    Abstract: Methods and compositions for detecting and treating diseases, especially cancer, and particularly breast, bladder, colon, gastrointestinal, kidney, liver, lung, melanoma, ovary, pancreatic, pharyngeal, prostate cancer and renal, associated with differential expression of prominin-1 (CD133) in disease cells compared to healthy cells. Also provided are antagonists or agonists of prominin-1, and methods for screening agents that modulate the prominin-1 level or activity in vivo or in vitro.
    Type: Application
    Filed: November 22, 2006
    Publication date: February 18, 2010
    Inventors: Karen Van Orden, Maria Leai Smith, Albina Nesterova, Candy Lee, Steve Ruben
  • Humanized antibodies to LIV-1 and use of same to treat cancer
    Patent number: RE48959
    Abstract: The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
    Type: Grant
    Filed: January 4, 2018
    Date of Patent: March 8, 2022
    Assignee: SEAGEN INC.
    Inventors: Maria Leia Smith, Django Sussman, William Arthur, Albina Nesterova